FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort

BACKGROUND: The role of second-line therapy in gastric cancer patients mostly stemmed from clinical trials with monochemotherapy carried out in Asian countries. Nevertheless, these results cannot be broadly generalized as molecular studies suggested the existence of different sets of deregulated gen...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Maugeri-Saccà, Marcello, Pizzuti, Laura, Sergi, Domenico, Barba, Maddalena, Belli, Franca, Fattoruso, Silvia Ileana, Giannarelli, Diana, Amodio, Antonella, Boggia, Sara, Vici, Patrizia, Di Lauro, Luigi
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2013
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3850248/
https://ncbi.nlm.nih.gov/pubmed/24330513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-67
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires